NDC 53808-0411

Xeloda

Capecitabine

Xeloda is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Capecitabine.

Product ID53808-0411_15601703-7442-48f3-89f4-44fef66b7514
NDC53808-0411
Product TypeHuman Prescription Drug
Proprietary NameXeloda
Generic NameCapecitabine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2009-07-01
Marketing CategoryNDA / NDA
Application NumberNDA020896
Labeler NameState of Florida DOH Central Pharmacy
Substance NameCAPECITABINE
Active Ingredient Strength500 mg/1
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 53808-0411-1

30 TABLET, FILM COATED in 1 BLISTER PACK (53808-0411-1)
Marketing Start Date2009-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53808-0411-1 [53808041101]

Xeloda TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020896
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-07-01
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
CAPECITABINE500 mg/1

OpenFDA Data

SPL SET ID:a732b303-9bbd-42ba-a7c5-61c21629ba93
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200328
  • 213293
  • UPC Code
  • 0300041101507
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Xeloda" or generic name "Capecitabine"

    NDCBrand NameGeneric Name
    0004-1100Xelodacapecitabine
    0004-1101Xelodacapecitabine
    53808-0411XelodaXeloda
    0054-0271CapecitabineCapecitabine
    0054-0272CapecitabineCapecitabine
    0093-7473CapecitabineCapecitabine
    0093-7474CapecitabineCapecitabine
    0378-2511Capecitabinecapecitabine
    0378-2512Capecitabinecapecitabine
    16714-467CAPECITABINECAPECITABINE

    Trademark Results [Xeloda]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    XELODA
    XELODA
    75241696 2200434 Live/Registered
    Hoffmann-La Roche Inc.
    1997-02-13

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.